Introduction: Basal cell carcinoma (BCC) of the umbilicus is an exceptional subtype of BCC with potential slowly progressing deeply invasive and wide growth pattern. Vismodegib is a hedgehog pathway inhibitor indicated for the treatment of large, nonoperable or metastatic BCC.
Δευτέρα 13 Αυγούστου 2018
Successful vismodegib debulking of a giant basal cell carcinoma of the umbilicus
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: Available online 25 July 2018 Source: Journal of Photochemistry and Photobiology B: Biology Author(s): Marco Ballestr...
-
Editorial AJR Reviewers: Heartfelt Thanks From the Editors and Staff Thomas H. Berquist 1 Share + Affiliation: Citation: American Journal...
-
Publication date: Available online 28 September 2017 Source: Actas Dermo-Sifiliográficas Author(s): F.J. Navarro-Triviño
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.